Korean J Otolaryngol-Head Neck Surg.
2003 Feb;46(2):134-138.
Immunohistochemical Study on bcl-2, c-myc, EGFR as Predictable Factor for Radiosensitivity in Early Glottic Cancer
- Affiliations
-
- 1Department of Otolaryngology-Head and Neck Surgery, Chonnam National University, Medical School, Gwangju, Korea. cjscyy@chonnam.ac.kr
Abstract
- BACKGROUND AND OBJECTIVES
The radiotherapy or surgery is the main treatment modality for early glottic cancer. The advantage of radiotherapy is the preservation of good voice quality after treatment but the main problem is increased complications in the salvage surgery when local control fails. So, it is important to predict the success of radiotherapy. The purpose of this study is to find predictable factors of the radiosensitivity in the early glottic cancer. MATERIALS AND METHOD: Immunohistochemical staining was performed on the paraffin sections of the biopsy specimens of 57 patients with early glottic cancer who had undertaken radiotherapy treatments in Chonnam National University Hospital from January 1988 to October 1998. Primary antibodies were the anti-bcl-2 monoclonal antibody, the anti-c-myc monoclonal antibody, and the anti-EGFR monoclonal antibodies. The relation between the local control outcome after radiotherapy and the result of immunostaining was analyzed by the chi-square and the Fisher's exact test. RESULTS: Positive expression of bcl-2 was 21.1% in the local controlled group and 12.3% in the uncontrolled group. There was no statistical significance between two groups. The expression rate of c-myc was statistically higher in the controlled group (36.8%) than in the uncontrolled group (7.0%) (p=0.025). Expression of EGFR was 57.9% in the controlled group and 22.5% in the uncontolled group. However, there was no statistical significance between two groups. CONCLUSION: The relation between the positive c-myc expression and the radiosensitivity suggests that c-myc might be a predictable factor of the radiosensitivity in early glottic cancer.
Keyword
MeSH Terms
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Expression of bcl-2 and c-myc Proteins in Epidermal and Melanocytic Tumors
- The Expression of c-myc, bcl-2 and p53 Proteins in Adenocarcinomas of Lung
- Expressions of bcl-2 and c-myc Protooncogenes and Their Relationship to the Proliferation and Apoptosis in Uterine Cervical Intraepithelial Neoplasia and Cervical Carcinoma
- Detection of bcl-2/IgH Gene Rearrangement and Expression of c-myc and p53 Oncoprotein in B-cell Lymphoma
- Frequency of bcl-2 mbr/JH Rearrangement and Prognostic Implication of bcl-2, c-myc Protein Expression in Non-Hodgkin's Lymphoma
